7 results
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
insulin requirements are ... Diabetes #Mellitus #DM2 ... #Medications #pharmacology ... #comparison #table ... #endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... oral route by using ... drug to remain stable ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
Insulin Calculations for Type 1 Diabetes 

Insulin-to-Carb Ratio (ICR) 500/TDD = #g of carbs covered by
calculations used in dosing ... normal mealtime dose ... Type1 #Diabetes #DM1 ... #Pharmacology # ... Endocrinology
Methotrexate Toxicology 

Intravenous leucovorin (folinic acid) treatment serves as a cofactor necessary for synthesis of thymidylate
Leucovorin dosing ... determining intravenous dosing ... , up to 100 mg/m2 ... evidence of marrow toxicity ... #Management #Pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
then be excreted using ... adjusting the dose ... cardiology #treatment #table ... #heartfailure #chf ... icu #clinical #pharmacology
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
Medications: K+, ACEi/ARBs ... NSAIDs, β-blockers, Antibiotics ... Na delivery): CHF ... Elimination (see Table ... Transient, repeat dose
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
at cumulative doses ... , 350 mg/m2, and ... every 3 months during ... cardiology #oncology #pharmacology ... #toxicity #chemotherapy